Heparin-induced thrombocytopenia differential diagnosis

Heparin-induced thrombocytopenia
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Heparin-induced thrombocytopenia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Heparin-induced thrombocytopenia differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Heparin-induced thrombocytopenia differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Heparin-induced thrombocytopenia differential diagnosis
CDC on Heparin-induced thrombocytopenia differential diagnosis
Heparin-induced thrombocytopenia differential diagnosis in the news
Blogs on Heparin-induced thrombocytopenia differential diagnosis
Directions to Hospitals Treating Heparin-induced thrombocytopenia
Risk calculators and risk factors for Heparin-induced thrombocytopenia differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2] Shyam Patel [3]

Overview

Heparin-induced thrombocytopenia is diagnosed when the platelet count falls by > 50% typically after 5-10 days of heparin therapy. It should be differentiated by other causes of thrombocytopenia like hemolytic uremic syndrome, thrombotic thrombocytopenia, disseminated intravascular coagulation, post-transfusion purpura, and systemic lupus erythematosis.

Differential diagnosis

HIT must be differentiated from other diseases that present with thrombocytopenia. Please scroll down to view the table.

Characteristic/Parameter	HIT	DIC	HUS	Atypical HUS	ITP	PTP	SLE
Symptoms	Bleeding, thrombosis, skin necrosis	Bleeding, thrombosis, petechiae, sepsis	Renal failure, hematuria, bleeding, microangiopathic hemolytic anemia	Renal failure, hematuria, bleeding, microangiopathic hemolytic anemia	Petechiae, bleeding, other autoimmune diseases	Petechiae, purpura, ecchymoses	Bleeding, photosensitivity, arthritis, malar rash, discoid rash, renal failure, seizures, psychosis
Platelet count	Low but usually more than 20000 per microliter	Low	Low	Low	Low; can be as low as 10000 per microliter	Low; can be less than 10000 per microliter; sudden onset after transfusion	Variable; usually low
PT and PTT	Normal	Elevated	Normal	Normal	Normal	Normal	Usually normal
Etiology	Heparin exposure	Sepsis, delivery of fetus, acute promyelocytic leukemia, other malignancy	E.coli strain O157:H7; Shiga-like toxin	Dysregulation of complement activation; mutation in complement factor H	Idiopathic; can be secondary to chronic lymphocytic leukemia, HIV, viral hepatitis, H. pylori	Exposure to transfused products	Autoimmunity with development of antibodies to DNA
Drug-related	Yes, always	Possible	No	No	Yes	No; transfusion-related	Possible; drug-induced lupus can be caused by medications like hydralazine or isoniazid
Bleeding	Possible	Usually	Usually	Usually	Yes; spontaneous bleeding if platelet count < 10000 per microliter	Yes; spontaneous bleeding if platelet count < 10000 per microliter	Rare

Table legend: HIT, heparin-induced thrombocytopenia; DIC, disseminated intravascular coagulation; HUS, hemolytic-uremic syndrome; ITP, immune thrombocytopenia purpura; PTP, post-transfusion purpura; SLE, systemic lupus erythematosis